Wall Street's busiest analysts issued a fresh batch of rating changes and price target adjustments on Friday, touching everything from airlines to apartments. Here's the complete rundown of what the smart money is thinking about ten companies making waves this week.
Pharmaceutical Plays Get More Optimistic
Needham analyst Serge Belanger isn't backing down on Kalvista Pharmaceuticals Inc (KALV), raising his price target from $32 to $35 while maintaining a Buy rating. The stock closed Thursday at $15.82, meaning Belanger sees more than double the upside if his thesis plays out.
Meanwhile, BTIG's Julian Harrison boosted his target on Ardelyx Inc (ARDX) from $14 to $17, keeping a Buy rating intact. Ardelyx shares finished Thursday at $7.00, suggesting Harrison sees the stock potentially more than doubling from current levels.
Energy Giant Hits a Speed Bump
Not everyone had good news to share. Baird analyst Ben Kallo downgraded GE Vernova Inc (GEV) from Outperform to Neutral, slashing the price target from $816 down to $649. With shares closing Thursday at $628.40, Kallo's new target implies limited upside from here, a notable shift in sentiment for the energy equipment company.




